Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Total Assets (Quarterly) : 376.71M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 376.71M |
| March 31, 2026 | 417.65M |
| December 31, 2025 | 449.08M |
| September 30, 2025 | 484.79M |
| June 30, 2025 | 197.39M |
| March 31, 2025 | 195.68M |
| Date | Value |
|---|---|
| December 31, 2024 | 164.31M |
| September 30, 2024 | 192.33M |
| June 30, 2024 | 189.87M |
| March 31, 2024 | 187.53M |
| December 31, 2023 | 0.3329M |
| December 31, 2022 | 0.1446M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 6.93M |
| IRulya Therapeutics, Inc. | 124.00M |
| PepGen Inc. | 141.40M |
| Q32 Bio, Inc. | 115.87M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.59M |
| Shareholders Equity (Quarterly) | 323.11M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 4.694 |
| Net Debt Paydown Yield | -0.08% |